Snowden Capital Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.11M | Buy |
+112,564
| New | +$3.11M | 0.09% | 224 |
|
|
2024
Q3 | – | Sell |
-2,897
| Closed | -$344K | – | 1249 |
|
|
2024
Q2 | $344K | Buy |
2,897
+345
| +14% | +$41K | 0.01% | 921 |
|
|
2024
Q1 | $272K | Buy |
+2,552
| New | +$272K | 0.01% | 993 |
|
|
2023
Q3 | – | Sell |
-3,210
| Closed | -$390K | – | 1141 |
|
|
2023
Q2 | $390K | Buy |
3,210
+153
| +5% | +$18.6K | 0.01% | 849 |
|
|
2023
Q1 | $469K | Buy |
3,057
+433
| +17% | +$66.5K | 0.02% | 759 |
|
|
2022
Q4 | $471K | Sell |
2,624
-621
| -19% | -$112K | 0.02% | 726 |
|
|
2022
Q3 | $383K | Sell |
3,245
-316
| -9% | -$37.3K | 0.02% | 774 |
|
|
2022
Q2 | $508K | Sell |
3,561
-1,579
| -31% | -$225K | 0.02% | 625 |
|
|
2022
Q1 | $885K | Buy |
5,140
+2,518
| +96% | +$434K | 0.04% | 473 |
|
|
2021
Q4 | $665K | Sell |
2,622
-804
| -23% | -$204K | 0.03% | 402 |
|
|
2021
Q3 | $1.32M | Buy |
3,426
+6
| +0.2% | +$2.31K | 0.07% | 317 |
|
|
2021
Q2 | $804K | Buy |
3,420
+50
| +1% | +$11.7K | 0.04% | 422 |
|
|
2021
Q1 | $441K | Buy |
3,370
+105
| +3% | +$13.8K | 0.03% | 524 |
|
|
2020
Q4 | $341K | Sell |
3,265
-748
| -19% | -$78.1K | 0.02% | 505 |
|
|
2020
Q3 | $284K | Buy |
+4,013
| New | +$284K | 0.02% | 477 |
|